Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
for
Castration Resistant Metastatic Prostate Cancer
Location: Boston MA, Baltimore MD, Minneapolis MN, Omaha NE,
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: Male
Age: 18 - 70+
Code: NCT04363164
Phase 2, Recruiting
Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma
for
Merkel Cell Carcinoma
Location: Boston MA, New York NY, Fairfax VA, Toronto,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT03787602
Phase 1, Phase 2, Recruiting
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT03310879
Phase 2, Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Boston MA, New York NY, Baltimore MD, Cleveland OH,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06034002
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CONFIRM: Magnetic Resonance Guided Radiation Therapy
for
Gastric Cancer, Invasive Breast Cancer, in Situ Breast Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18+
Code: NCT04368702
Recruiting
Developing Fast Pediatric Imaging
for
Pediatric Low-grade Gliomas
Location: Boston MA
Sponsor: Boston Children's Hospital
Sex: All
Age: 0+
Code: NCT03761121
Recruiting
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
for
EGFRI Induced Acneiform Lesions
Location: Boston MA, New York NY, Neptune NJ, Philadelphia PA,
Sponsor: Lutris Pharma Ltd.
Sex: All
Age: 18+
Code: NCT04759664
Phase 2, Recruiting
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
for
Acute Myeloid Leukemia,
Location: Boston MA, Baltimore MD, Chapel Hill NC, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05886049
Phase 1, Recruiting
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
for
Solid Tumor, Adult, Mesothelioma, NSCLC
Location: Boston MA, New York NY, Arlington VA, Chicago IL,
Sponsor: Vivace Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT04665206
Phase 1, Phase 2, Recruiting
Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
for
Relapsed Classic Hodgkin Lymphoma
Location: Boston MA, Hackensack NJ, Chicago IL, Nashville TN,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT04561206
Phase 2, Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
for
Triple Negative Breast Cancer, Breast Cancer,
Location: Boston MA, New York NY, Fairfax VA, Detroit MI,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05377996
Phase 1, Phase 2, Recruiting
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
Location: Boston MA, Providence RI, Mineola NY, Hackensack NJ,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05836324
Phase 1, Recruiting
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Boston MA, Stony Brook NY, New York NY, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06140524
Phase 2, Recruiting
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
for
Advanced Malignant Solid Neoplasm,
Location: Boston MA, Mineola NY, New York NY, Bethesda MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05687136
Phase 1, Recruiting
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors